Acquisition of Cabozantinib-Sensitive MET D1228N Mutation During Progression on Crizotinib in MET-Amplified Triple-Negative Breast Cancer

Overview of attention for article published in Clinical Breast Cancer, February 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 19 Mendeley

So far, Altmetric has seen 1 X post from an account with 416 followers.

“Acquisition of #Cabozantinib -Sensitive MET D1228N Mutation During Progression on #Crizotinib in MET-Amplified Triple-Negative #BreastCancer”. With @DrBenParsons in Aug issue of Clinical Breast Cancer https://t.co/TtiGUuFKhj #TNBC https://t.co/KEO8wgQxHx

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.